Revolutionizing Cerebrovascular Repair

Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke

Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice

Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis

Epidermal Growth Factor and Perlecan Fragments Produced by Apoptotic Endothelial Cells Co-Ordinately Activate ERK1/2-Dependent Antiapoptotic Pathways in Mesenchymal Stem Cells

Perlecan Domain V Inhibits Amyloid-β Induced Brain Endothelial Cell Toxicity and Restores Angiogenic Function

Perlecan domain V inhibits alpha-2 integrin-mediated amyloid-beta neurotoxicity

Stream Biomedical, Inc., a privately held clinical-stage biopharmaceutical company, is dedicated to the development of first-in-class targeted therapeutics for the treatment of  acute neurotrauma and chronic neurodegenerative diseases of high unmet need.

Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025